Click a link below to view the mailing archive as if it had been sent to you.
| 2021-04-30 12:15 | | Keytruda should lose stomach cancer indication, says ODAC and more... |
| 2021-04-30 00:15 | | After $600M sales hit from pandemic, Merck's open to 'all forms' of M&A deals, incoming CEO says and more... |
| 2021-04-29 12:15 | | Biotech Tilts at the Tipping Point of Gender Equality and more... |
| 2021-04-29 00:15 | | ODAC votes to keep Keytruda and Tecentriq accelerated approvals in bladder cancer and more... |
| 2021-04-28 12:15 | | Pfizer buys Amplyx to grow infectious disease pipeline and more... |
| 2021-04-28 00:15 | | FDA panel questions Roche’s Tecentriq-Abraxane combo in breast cancer, but votes to keep approval in place for now and more... |
| 2021-04-27 12:15 | | What are Merck, Bristol Myers and Roche planning for the big FDA cancer approval review? and more... |
| 2021-04-27 00:15 | | CureVac's Potential Has Wall Street Sending Mixed Signals and more... |
| 2021-04-26 12:15 | | US resumes COVID vaccinations with J&J shot after safety review and more... |
| 2021-04-26 00:15 | | CEO Salaries for the Top 20 Pharma Companies by Market Cap and more... |
| 2021-04-23 12:15 | | Inovio's COVID-19 vaccine funding axed as US says thanks but no thanks and more... |
| 2021-04-23 00:15 | | A look ahead at the FDA meeting that could decide the future of 6 cancer drug approvals and more... |
| 2021-04-22 12:15 | | Bristol Myers, flush with pair of CAR-T approvals, blueprints first cell therapy factory in Europe and more... |
| 2021-04-22 00:15 | | Biogen’s Alzheimer’s hopeful aducanumab faces ‘less than a coin flip’s chance’ of FDA approval: analysts and more... |
| 2021-04-21 12:15 | | Biopharma ramps up lobbying spend as drug pricing legislation nears and more... |
| 2021-04-21 00:15 | | The next 2 months in biotech and pharma will be busy. Here's what to watch. and more... |
| 2021-04-20 12:15 | | J&J Shareholders Urged by Others to Reject CEO's $30 Million Payday and more... |
| 2021-04-20 00:15 | | Bristol Myers’ Opdivo Receives FDA Approval for Gastric Cancer and more... |
| 2021-04-19 12:15 | | The Moderna CEO's Bold Statement That May Mean Bad News for Novavax and more... |
| 2021-04-19 00:15 | | Speak up, docs: Bayer's 'AMI' voice assistant talks prescription drug info for physicians and more... |
| 2021-04-18 12:15 | | Moderna cuts COVID-19 vaccine deliveries to Canada, U.K. amid European supply struggles and more... |
| 2021-04-16 12:15 | | In highly unusual move, Pacira sues medical journal for libel over its non-opioid painkiller and more... |
| 2021-04-16 00:15 | | Alnylam CEO Maraganore scored $7.8M in 2020 pay. Or was it $13.6M? Depends how you view the numbers and more... |
| 2021-04-15 12:15 | | Novartis inks 3rd COVID-19 production pact, this time for Roche's arthritis med Actemra and more... |
| 2021-04-15 00:15 | | CDC advisory panel delays decision on Johnson & Johnson Covid-19 vaccine and more... |
| 2021-04-14 12:15 | | Moderna and Novavax added to ‘mix and match’ COVID-19 vaccine trial and more... |
| 2021-04-14 00:15 | | Lilly, Arch join Deerfield in backing new gene therapy biotech Jaguar and more... |
| 2021-04-13 12:15 | | Feds call halt to Johnson & Johnson COVID-19 vaccine rollout after 'extremely rare' blood clot cases and more... |
| 2021-04-13 00:15 | | 5 takeaways from AACR, one of the year's top meetings on cancer drugs and more... |
| 2021-04-12 12:15 | | Regeneron’s Covid mAb as a prophylactic injection: Reduced risk of symptomatic infection by 81% and more... |
| 2021-04-12 00:15 | | Lilly gene-targeted drug shows potential for use across cancers and more... |
| 2021-04-09 12:15 | | Scientists work toward an elusive dream: a simple pill to treat Covid-19 and more... |
| 2021-04-09 00:15 | | Did pharma overshoot digital sales rep calls? Study charts decline in effectiveness and more... |
| 2021-04-08 12:15 | | Merck's Keytruda, on the heels of a first-line kidney cancer win, targets earlier, post-surgery use and more... |
| 2021-04-08 00:15 | | Vaccitech confidentially files for Nasdaq IPO and more... |
| 2021-04-07 12:15 | | Sanofi forms nonprofit unit to provide essential medicines to some low-income countries and more... |
| 2021-04-07 00:15 | | Biden Tax Plan Seen Hitting Tech, Pharmaceutical Companies and more... |
| 2021-04-06 12:15 | | AstraZeneca COVID-19 vaccine linked to rare blood clots, EMA official says, but benefits still outweigh risks and more... |
| 2021-04-06 00:15 | | After name change and dropped IPO, IN8bio tries again to boost its cancer pipeline and more... |
| 2021-04-02 12:15 | | Regeneron shoots for longer Eylea dosing interval in diabetic retinopathy with NIH data and more... |
| 2021-04-02 00:15 | | Pfizer vaccine data show durable protection, hint at efficacy against virus variant and more... |
| 2021-04-01 12:15 | | Bristol Myers faces $1B+ tax fight after accidental disclosure reveals alleged offshore patents scheme — report and more... |
| 2021-04-01 00:15 | | Astellas gene therapy repairs damage in neurodegenerative disease models and more... |
